Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.

Movement disorders : official journal of the Movement Disorder Society - 30 Jan 2009

Camicioli Richard M, Bouchard Thomas P, Somerville Martin J

Abstract excerpt

Levodopa (L-dopa) treatment of Parkinson's disease (PD) is associated with elevated homocysteine (Hcy). To examine the relationship between Hcy, methylenetetrahydrofolate reductase polymorphisms (MTHFR: 677C/T; 1298A/C), and B-vitamins in older PD patients and whether Hcy or MTHFR polymorphisms were associated with clinical measures. MTHFR polymorphisms, B-vitamin intake, and blood concentrations of Hcy, vitamin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Creatinine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Folic Acid

Share to Homocysteine

Share to Inactivation, Metabolic

Share to Levodopa

Share to Motor Skills

Share to Vitamin B Complex

Source

Identifiers

PMID: 18951534
DOI: 10.1002/mds.22227

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.PMID 18951534Read ↗

Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients.Semantic proximity Read ↗

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.Semantic proximity Read ↗

Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic studySemantic proximity Read ↗

Homocysteine levels, genetic background, and cognitive impairment in Parkinson's disease.Semantic proximity Read ↗

Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson's disease: a meta-analysis.Semantic proximity Read ↗

Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease.Semantic proximity Read ↗

Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapySemantic proximity Read ↗

Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson's Disease: A Preliminary Cross-Sectional Study.Semantic proximity Read ↗

Brain B Vitamin Status and One-Carbon Metabolism Gene Polymorphisms are Associated with Cognitive Impairment in Alzheimer’s and Parkinson’s DiseaseSemantic proximity Read ↗

Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.Semantic proximity Read ↗

The MTHFR C677T polymorphism modifies age at onset in Parkinson's disease.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase C677T genotype and PD.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.